Last reviewed · How we verify

NCT03387956

Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting

Completed NA Last updated 6 June 2018
What this trial tests

NA trial testing Intrathecal atropine in Postoperative Nausea in 120 participants. Completed in 10 August 2017.

Timeline
20 March 2017
Primary endpoint
28 July 2017
10 August 2017

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment120
Start date20 March 2017
Primary completion28 July 2017
Estimated completion10 August 2017
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 20 to 40, female only, with Postoperative Nausea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

optimal postoperative pain control with intrathecal morphine, with proper prevention of postoperative nausea and vomiting. Dexamethasone, and or atropine could offer some protection against nausea and vomiting.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section.
    Griffiths JD, Gyte GM, Popham PA, Williams K, et al · · 2021 · cited 10× · PMID 34002866 · DOI 10.1002/14651858.cd007579.pub3

Verify or expand the search:

Other recruiting trials for Postoperative Nausea

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03387956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing